Epidemiology of urological infections: a global burden

  • Recep ÖztürkEmail author
  • Ahmet Murt
Topic Paper



Urinary tract infections (UTIs) are among the most frequent infections in clinical practice worldwide. Their frequency and burden must be higher than available data suggest because they are not among mandatory diseases to be notified.

Classification of urinary infections

Although there are many different proposals for classifying UTIs, classifications based on acquisition settings and complication status are more widely used. These include community- acquired UTIs (CAUTIs) or healthcare-associated UTIs (HAUTIs) and uncomplicated or complicated UTIs.

Epidemiology of urological infections and global burden

As the most frequently seen infectious disease, CAUTIs affect more than 150 million people annually. Complicated UTIs in particular constitute a huge burden on healthcare systems as a frequent reason for hospitalization. The prevalence of HAUTIs ranges between 1.4% and 5.1%, and the majority of them are catheter-related UTIs. Community-onset HAUTIs have gained importance in recent years.


As frequent infectious diseases, UTIs create clinical and economic burdens on healthcare systems, and they also affect quality of life determinants.


Community-acquired urinary tract infection Community-onset healthcare-associated urinary tract infection Epidemiology Global burden Healthcare-associated urinary tract infection Urological infections 


Author contribution

ÖR: Review and analysis of the literature, developing the general framework and synthesizing the available data, writing the manuscript. MA: Review of the literaute, writing the manuscript, preparing the final work for submission.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.

Human and animal rights

Not applicable as this is a review article.

Informed consent

Not applicable as this is a review article.


  1. 1.
    Foxman B (2002) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113(Suppl 1A):5S–13SPubMedCrossRefGoogle Scholar
  2. 2.
    Cardwell SM, Crandon JL, Nicolau DP, McClure MH, Nailor MD (2016) Epidemiology and economics of adult patients hospitalized with urinary tract infections. Hosp Pract 44(1):33–40CrossRefGoogle Scholar
  3. 3.
    Bonkat G, Pickard R, Bartoletti R, Cai T, Bruyère F, Geerlings SE, Köves B, Wagenlehner F (2018) Guidelines on urological infections 2018, Accessed June 2019.
  4. 4.
    Tandogdu Z, Wagenlehner FM (2016) Global epidemiology of urinary tract infections. Curr Opin Infect Dis 29(1):73–79PubMedCrossRefGoogle Scholar
  5. 5.
    Saint S, Kowalski CP, Forman J, Damschroder L, Hofer TP, Kaufman SR, Creswell JW, Krein SL (2008) A multicenter qualitative study on preventing hospital-acquired urinary tract infection in US hospitals. Infect Control Hosp Epidemiol 29(4):333–341PubMedCrossRefGoogle Scholar
  6. 6.
    Johansen TE, Botto H, Cek M, Grabe M, Tenke P, Wagenlehner FM, Naber KG (2011) Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system. Int J Antimicrob Agents 38(Suppl):64–70PubMedCrossRefGoogle Scholar
  7. 7.
    Medina M, Castillo-Pino E (2019) An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol 11:1756287219832172PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Lichtenberger P, Hooton TM (2008) Complicated urinary tract infections. Curr Infect Dis Rep 10(6):499–504PubMedCrossRefGoogle Scholar
  9. 9.
    Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ (2015) Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13(5):269–284PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Stamm WE, Norrby SR (2001) Urinary tract infections: disease panorama and challenges. J Infect Dis 183(Suppl 1):S1–S4PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Taur Y, Smith MA (2007) Adherence to the Infectious Diseases Society of America guidelines in the treatment of uncomplicated urinary tract infection. Clin Infect Dis 44(6):769–774PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Schappert SM, Rechtsteiner EA (2011) Ambulatory medical care utilization estimates for 2007 National Center for Health Statistics. Vital Health Stat 13(169):1–38Google Scholar
  13. 13.
    Foxman B (2014) Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am 28(1):1–13PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Foxman B (2010) The epidemiology of urinary tract infection. Nature Rev Urol 7(12):653–660CrossRefGoogle Scholar
  15. 15.
    Mazzulli T (2002) Resistance trends in urinary tract pathogens and impact on management. J Urol 168(4 Pt 2):1720–1722PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Scottish Intercollegiate Guidelines Network (2012) Management of suspected bacterial urinary tract infection in adults. ( Accessed July 2019.
  17. 17.
    Gücük A, Burgu B, Gökçe İ, Mermerkaya M, Soygür T (2013) Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR ? J Pediatr Urol 9:1131–6PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Griebling TL (2005) Urologic diseases in America project: trends in resource use for urinary tract infections in men. J Urol 173(4):1288–1294PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Griebling TL (2005) Urologic diseases in America project: trends in resource use for urinary tract infections in women. J Urol 173(4):1281–1287PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Hoberman A, Chao HP, Keller DM, Hickey R, Davis HW, Ellis D (1993) Prevalence of urinary tract infection in febrile infants. J Pediatr 123(1):17–23PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Sood A, Penna FJ, Eleswarapu S, Pucheril D, Weaver J, Abd-El-Barr AE, Wagner JC, Lakshmanan Y, Menon M, Trinh QD, Sammon JD, Elder JS (2015) Incidence, admission rates, and economic burden of pediatric emergency department visits for urinary tract infection: data from the nationwide emergency department sample, 2006 to 2011. J Pediatr Urol 11(5):246.e1–8CrossRefGoogle Scholar
  22. 22.
    Hooton TM, Scholes D, Stapleton AE, Roberts PL, Winter C, Gupta K, Samadpour M, Stamm WE (2000) A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med 343(14):992–997PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Moore EE, Hawes SE, Scholes D, Boyko EJ, Hughes JP, Fihn SD (2008) Sexual intercourse and risk of symptomatic urinary tract infection in post-menopausal women. J Gen Intern Med 23(5):595–599PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Vincent CR, Thomas TL, Reyes L, White CL, Canales BK, Brown MB (2013) Symptoms and risk factors associated with first urinary tract infection in college age women: a prospective cohort study. J Urol 189(3):904–910PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD (2000) Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 10(8):509–515PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Frances CJ, Cullen KA, Kozak LJ, National Hospital Discharge Survey (2007) (2005) Annual summary with detailed diagnosis and procedure data. National Center for Health Statistics. Vital Health Stat 13(165):1–20Google Scholar
  27. 27.
    François M, Hanslik T, Dervaux B, Le Strat Y, Souty C, Vaux S, Maugat S, Rondet C, Sarazin M, Heym B, Coignard B, Rossignol L (2016) The economic burden of urinary tract infections in women visiting general practices in France:a cross-sectional survey. BMC Health Serv Res 16:365PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Ciani O, Grassi D, Tarricone R (2013) An economic perspective on urinary tract infection: the “costs of resignation”. Clin Drug Investig 33(4):255–261PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Brown P, Moran K, Foxman B (2005) Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy. Pharmacoeconomics 23(11):1123–1142PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Vallejo-Torres L, Pujol M, Shaw E, Wiegand I, Vigo JM, Stoddart M, Grier S, Gibbs J, Vank C, Cuperus N, van den Heuvel L, Eliakim-Raz N, Carratala J, Vuong C, MacGowan A, Babich T, Leibovici L, Addy I, Morris S, RESCUING Study Group, and Study Sites (2018) Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET. RESCUING study. BMJ Open 8(4):e020251**CrossRefGoogle Scholar
  31. 31.
    Cek M, Tandogdu Z, Wagenlehner F, Tenke P, Naber K, Bjerklund-Johansen TE (2014) Healthcare-associated urinary tract infections in hospitalized urological patients: a global perspective results from the GPIU studies 2003–2010. World J Urol 32(6):1587–1594PubMedCrossRefGoogle Scholar
  32. 32.
    Wagenlehner F, Wullt B, Ballarini S, Zingg D, Naber KG (2018) Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT). Expert Rev Pharmacoecon Outcomes Res 18(1):107–117PubMedCrossRefGoogle Scholar
  33. 33.
    Renard J, Ballarini S, Mascarenhas T, Zahran M, Quimper E, Choucair J, Iselin CE (2015) recurrent lower urinary tract infections have a detrimental effect on patient quality of life: a prospective, observational study. Infect Dis Ther 4(1):125–135CrossRefGoogle Scholar
  34. 34.
    Ronald A (2002) The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 113(Suppl 1A):14S–19SPubMedCrossRefGoogle Scholar
  35. 35.
    Gupta K, Bhadelia N (2014) Management of urinary tract infections from multidrug-resistant organisms. Infect Dis Clin North Am 28(1):49–59PubMedCrossRefGoogle Scholar
  36. 36.
    MacVane SH, Tuttle LO, Nicolau DP (2014) Impact of extended-spectrum β–lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection. J Hosp Med 9(4):232–238PubMedCrossRefGoogle Scholar
  37. 37.
    Esteve-Palau E, Solande G, Sánchez F, Sorlí L, Montero M, Güerri R, Villar J, Grau S, Horcajada JP (2015) Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: a matched cohort study. J Infect 71(6):667–674PubMedCrossRefGoogle Scholar
  38. 38.
    Hanna-Wakim RH, Ghanem ST, El Helou MW, Khafaja SA, Shaker RA, Hassan SA, Saad RK, Hedari CP, Khinkarly RW, Hajar FM, Bakhash M, El Karah D, Akel IS, Rajab MA, Khoury M, Dbaibo GS (2015) Epidemiology and characteristics of urinary tract infections in children and adolescents. Front Cell Infect Microbiol 5:45PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Kizilca O, Siraneci R, Yilmaz A, Hatipoglu N, Ozturk E, Kiyak A, Ozkok D (2012) Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children. Pediatr Int 54(6):858–862PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Shaw E, Addy I, Stoddart M, Vank C, Grier S, Wiegand I, Leibovici L, Eliakim-Raz N, Vallejo-Torres L, Morris S, MacGowan A, Carratalà J, Pujol M, COMBACTE-MAGNET Consortium (2016) Retrospective observational study to assess the clinical management and outcomes of hospitalised patients with complicated urinary tract infection in countries with high prevalence of multidrug resistant Gram-negative bacteria (RESCUING). BMJ Open 6(7):e011500PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin S, Emerging Infections Program Healthcare-Associated Infections Antimicrobial Use Prevalence Survey Team (2014) Multistate point-prevalence survey of healthcare-associated infections. N Engl J Med 370(13):1198–1208PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    European Centre for Disease prevention and Control (2013) Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2011-2012. Stockholm: European Centre for Disease prevention and Control, Accessed July 2019.
  43. 43.
    Allegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L, Pittet D (2011) Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 377(9761):228–241PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Suetens C, Hopkins S, Kolman J, Diaz Högberg LD (2012) Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2011–2012. European Center of Disease Prevention and Control Accesed July 2019.
  45. 45.
    Gardner A, Mitchell B, Beckingham W, Fasugba O (2014) A point prevalence cross sectional study of healthcare-associated urinary tract infections in six Australian hospitals. BMJ Open 4(7):e005099PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Cassini A, Plachouras D, Eckmanns T, Abu Sin M, Blank HP, Ducomble T, Haller S, Harder T, Klingeberg A, Sixtensson M, Velasco E, Weiß B, Kramarz P, Monnet DL, Kretzschmar ME, Suetens C (2016) Burden of six healthcare-associated infections on european population health: estimating incidence-based disability-adjusted life years through a population prevalence-based modelling study. PLoS Med 13(10):e1002150PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Tandogdu Z, Cek M, Wagenlehner F, Naber K, Tenke P, van Ostrum E, Johansen TB (2014) Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study. World J Urol 32(3):791–801PubMedPubMedCentralGoogle Scholar
  48. 48.
    Wagenlehner F, Naber K, Tenke P, van Ostrum E, Johansen TB (2014) Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study. World J Urol 32(3):791–801PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Hartstein AI, Garber SB, Ward TT, Jones SR, Morthland VH (1981) Nosocomial urinary tract infection: a prospective evaluation of 108 catheterized patients. Infect Control 2(5):380–386PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Saint S (2000) Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am J Infect Control 28(1):68–75PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Lo E, Nicolle LE, Coffin SE, Gould C, Maragakis LL, Meddings J, Pegues DA, Pettis AM, Saint S, Yokoe DS (2014) Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 35(5):464–479PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Chenoweth CE, Gould CV, Saint S (2014) Diagnosis, management, and prevention of catheter-associated urinary tract infections. Infect Dis Clin North Am 28(1):105–119PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Maki DG, Tambyah PA (2001) Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 7(2):342–347PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Warren JW, Damron D, Tenney JH, Hoopes JM, Deforge B, Muncie HL Jr (1987) Fever, bacteremia, and death as complications of bacteriuria in women with long-term urethral catheters. J Infect Dis 155(6):1151–1158PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Rosenthal VD, Dwivedy A, Calderón ME, Esen S, Hernández HT, Abouqal R, Medeiros EA, Espinoza TA, Kanj SS, Gikas A, Barnett AG, Graves N, International Nosocomial Infection Control Consortium (INICC) Members (2011) Time-dependent analysis of length of stay and mortality due to urinary tract infections in ten developing countries: INICC findings. J Infect 62(2):136–141PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Pegues DA, Healthcare Infection Control Practices Advisory Committee (2010) Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol 31(4):319–26PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Tambyah PA, Knasinski V, Maki DG (2002) The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect Control Hosp Epidemiol 23(1):27–31PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Burton DC, Edwards JR, Srinivasan A, Fridkin SK, Gould CV (2011) Trends in catheter-associated urinary tract infections in adult intensive care units–United States, 1990–2007. Infect Control Hosp Epidemiol 32(8):748–756PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    World Health Organization (2011). Report on the Burden of Endemic Health Care-Associated Infection Worldwide a systematic review of the literature .;jsessionid=64A964F12A0FAA73F2166B89CD63F264?sequence=1 Accessed July 2019.
  60. 60.
    Weiner LM, Webb AK, Limbago B, Dudeck MA, Patel J, Kallen AJ, Edwards JR, Sievert DM (2016) Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the centers for disease control and prevention, 2011–2014. Infect Control Hosp Epidemiol 37(11):1288–1301PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Graves N, Tong E, Morton AP, Halton K, Curtis M, Lairson D, Whitby M (2007) Factors associated with health care-acquired urinary tract infection. Am J Infect Control 35(6):387–392PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Laupland KB, Zygun DA, Davies HD, Church DL, Louie TJ, Doig CJ (2002) Incidence and risk factors for acquiring nosocomial urinary tract infection in the critically ill. J Crit Care 17(1):50–57PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    World Health Organization (2019) Healthcare Associated Infection. Fact Sheet. Accessed July 2019.
  64. 64.
    Gordon KA, Jones RN (2003) Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000). Diagn Microbiol Infect Dis 45(4):295–301PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Medina-Polo J, Arrebola-Pajares A, Perez-Cadavid S, Benítez-Sala R, Sopeña-Sutil R, Lara-Isla A, Alsonso-Isa M, Gil-Moradillo J, Justo-Quintas J, Miranda-Utrera N, Aguilar-Gisbert L, Passas-Martínez JB, Tejido-Sánchez Á (2015) Extended-spectrum beta-lactamase-producing bacteria in a urology ward: epidemiology, risk factors and antimicrobial susceptibility patterns. Urol Int 95(3):288–292PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Zilberberg MD, Nathanson BH, Sulham K, Fan W, Shorr AF (2017) Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis. BMC Infect Dis 17(1):279PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Tabak YP, Sung AH, Ye G, Vankeepuram L, Gupta V, McCann E (2019) Attributable clinical and economic burden of carbapenem-non-susceptible Gram-negative infections in patients hospitalized with complicated urinary tract infections. J Hosp Infect 102(1):37–44PubMedCrossRefPubMedCentralGoogle Scholar
  68. 68.
    Aguilar-Duran S, Horcajada JP, Sorli L, Montero M, Salvadó M, Grau S, Gómez J, Knobel H (2012) Community-onset healthcare-related urinary tract infections: comparison with community and hospital acquired urinary tract infections. J Infect 64(5):478–483PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Saltoglu N, Karali R, Yemisen M, Ozaras R, Balkan II, Mete B, Tabak F, Mert A, Hondur N, Ozturk R (2015) Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities. Int J Clin Pract 69(7):766–770PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Zhanel GG, Harding GK, Nicolle LE (1991) Asymptomatic bacteriuria in patients with diabetes mellitus. Rev Infect Dis 13(1):150–154PubMedCrossRefGoogle Scholar
  71. 71.
    Mody L, Juthani-Mehta M (2014) Urinary tract infections in older women: a clinical review. JAMA 311(8):844–854PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Ruben FL, Dearwater SR, Norden CW, Kuller LH, Gartner K, Shalley A, Warshafsky G, Kelsey SF, O'Donnell C, Means E, Amoroso W, Bochicchio G (1995) Clinical infections in the noninstitutionalized geriatric age group: methods utilized and incidence of infections The Pittsburgh Good Health Study. Am J Epidemiol 141(2):145–157PubMedCrossRefGoogle Scholar
  73. 73.
    Eriksson I, Gustafson Y, Fagerstrom L, Olofsson B (2010) Prevalence and factors associated with urinary tract infections (UTIs) in very old women. Arch Gerontol Geriatr 50(2):132–135PubMedCrossRefGoogle Scholar
  74. 74.
    Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Houton TM, Infectious Diseases Society of America; American Society of Nephrology; American Geriatric Society (2005) Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clinical Infectious Diseases 40(5):643–654PubMedCrossRefGoogle Scholar
  75. 75.
    Mittal P, Wing DA (2005) Urinary tract infections in pregnancy. Clin Perinatol 32(3):749–764PubMedCrossRefGoogle Scholar
  76. 76.
    Patterson TF, Andriole VT (1997) Detection, significance, and therapy of bacteriuria in pregnancy. Update in the managed health care era. Infect Dis Clin North Am 11(3):593–608PubMedCrossRefGoogle Scholar
  77. 77.
    Smaill FM, Vazquez JC (2015) Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. CrossRefPubMedGoogle Scholar
  78. 78.
    Matuszkiewicz-Rowińska J, Małyszko J, Wieliczko M (2015) Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Arch Med Sci 11(1):67–77PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    Schnarr J, Smaill F (2008) Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy. Eur J Clin Invest 38(Suppl 2):50–57PubMedCrossRefGoogle Scholar
  80. 80.
    Wing DA, Fassett MJ, Getahun D (2014) Acute pyelonephritis in pregnancy: an 18-year retrospective analysis. Am J Obstet Gynecol 210(3):219.e1–6CrossRefGoogle Scholar
  81. 81.
    Ness D, Olsburgh J (2019) UTI in kidney transplant. World J Urol. CrossRefPubMedPubMedCentralGoogle Scholar
  82. 82.
    Alevizakos M, Nasioudis D, Mylonakis E (2017) Urinary tract infections caused by ESBL-producing Enterobacteriaceae in renal transplant recipients: a systematic review and meta-analysis. Transpl Infect Dis 19(6):e12759CrossRefGoogle Scholar
  83. 83.
    Marion TE, Rivers CS, Kuerban D, Cheng CL, Fallah N, Batke J, Dvorak MF, Fisher CG, Kwon BK, Noonan VK, Street JT (2017) Previously identified common post-injury adverse events in traumatic spinal cord injury validation of existing literature and relation to selected potentially modifiable comorbidities: a prospective Canadian cohort study. J Neurotrauma 34(20):2883–2891PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2020

Authors and Affiliations

  1. 1.Department of Infectious Diseases and Clinical MicrobiologyIstanbul Medipol University, School of MedicineIstanbulTurkey
  2. 2.Department of Internal Medicine, Nephrology UnitIstanbul University-Cerrahpasa, Cerrahpasa Medical FacultyIstanbulTurkey

Personalised recommendations